Trials / Conditions / Essential Arterial Hypertension
Essential Arterial Hypertension
5 registered clinical trials studyying Essential Arterial Hypertension — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension NCT06608472 | Eurofarma Laboratorios S.A. | Phase 3 |
| Completed | Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertens NCT04927299 | Laboratorios Silanes S.A. de C.V. | Phase 3 |
| Withdrawn | Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorot NCT02521246 | EMS | Phase 3 |
| Withdrawn | Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control NCT02521233 | EMS | Phase 3 |
| Withdrawn | Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control NCT02493322 | EMS | Phase 3 |